科研速览继续刷下去 →
◆ Cardiovascular revascularization medicine : including molecular interventions2026-08-22

Balloon angioplasty for coronary artery disease: Best practices in the DCB era.

Shreesh Kalagi, Ricardo O Escarcega, Angela M Taylor, Michael Ragosta, George W Vetrovec, Michael J Lipinski

原始摘要(原文)
As percutaneous coronary intervention with drug-coated balloon (DCB) increases, it will be critical to revisit criteria to define an optimal balloon angioplasty result. Given the importance of adequate vessel preparation prior to consideration of DCB utilization, many interventional cardiologists may be unfamiliar with what percentage of residual stenosis is considered acceptable following balloon angioplasty and which coronary dissections are safe to leave. Intravascular imaging may provide a powerful tool to aid in determining which lesions are safe to proceed with DCB use following vessel preparation and which lesions require bailout stenting. As DCB use expands into the treatment of de novo coronary lesions in the United States, employment of best practices and understanding whether a balloon angioplasty result is optimal will be critical for successful adoption of DCB technology.
读原文 ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文

Balloon angioplasty for coronary artery disease: Best practices in the DCB era. — 科研速览 Science Skim